PLUS THERAPEUTICS, INC. — Director's Dealing 2012

Jan 4, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2012-01-01

Reporting Person: HAWRAN PAUL W (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-01-01	Restricted Stock Award (Common Stock)	A	10000	—	Acquired	81610	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-01-01	Non-Qualified Stock Option	$2.20	A	15000	Acquired	2022-01-01	Common Stock (15000)	Direct

Footnotes

F1: The Restricted Stock Award vests in full on December 31, 2012.

F2: The option vests 1/24th per month from date of grant, subject to the termsof the Company's 2004 Equity Incentive Plan,